Menu
PacPremier
Magic Hour
Montecito
Loading...
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Amgen clinical trial shows promising results for migraine drug Aimovig

By   /   Tuesday, April 17th, 2018  /   Comments Off on Amgen clinical trial shows promising results for migraine drug Aimovig

    Print       Email
Amgen, the biotech giant based in Thousand Oaks, announced promising results for a clinical trial of its experimental migraine treatment Aimovig on April 17. The announcement was made after markets closed. According to a news release, the late-stage trial found that it “reduced episodic migraines by at least half in 30 percent of patients who…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Carpinteria-based Procore Technologies moved up from No. 880 last year to No. 697 this year. (Nik Blaskovich)

Procore announces second recent acquisition

Read More →